OOIR: Observatory of International Research

Papers

(The median citation count of Endocrine Reviews is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Papillary Craniopharyngioma: An Integrative and Comprehensive Review	380
Insulin/IGF signaling in islet biology and its therapeutic implications	333
Antiobesity Pharmacotherapy for Patients With Genetic Obesity Due to Defects in the Leptin-Melanocortin Pathway	321
Single-Cell Landscapes of Adipose-Derived Mesenchymal Stem Cells: From Homeostatic Regulators to Obesity-Driven Central Hubs	195
Update and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome	189
Correction to: “ER Stress in Cardiometabolic Diseases: From Molecular Mechanisms to Therapeutics”	165
DNA Damage and Repair in Thyroid Physiology and Disease	140
Growth Hormone Action as a Target in Cancer: Significance, Mechanisms, and Possible Therapies	128
LGR4: A New Receptor Member in Endocrine and Metabolic Diseases	124
Medical Treatment of Acromegaly: Navigating the Present, Shaping the Future	112
MASLD and the Cardiovascular-Kidney-Liver-Metabolic syndrome	112
Bone in Parathyroid Diseases Revisited: Evidence From Epidemiological, Surgical and New Drug Outcomes	106
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention	104
The Molecular Biology of Midgut Neuroendocrine Neoplasms	101
The Pregnancy-Associated Plasma Protein-A (PAPP-A) Story	100
A Critical Assessment of Fasting to Promote Metabolic Health and Longevity	96
Effects of Maternal Vitamin D Supplementation on Childhood Health	90
Correction to: “The Congenital and Acquired Mechanisms Implicated in the Etiology of Central Precocious Puberty”	89
Calcium-Sensing Receptor Regulation of Gastrointestinal Hormone Secretion	86
Sex hormones and exercise in the musculoskeletal system: from signaling to structure and function	83
Lung carcinoids (lung neuroendocrine tumors): integrated classification, molecular biology, diagnosis, and multidisciplinary management	78
The Biology and Clinical Implications of PCSK7	77
Recent Advances in the Role of Autophagy in Endocrine-Dependent Tumors	74
The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism	72
Advances in the Treatment of Gastroenteropancreatic Neuroendocrine Carcinomas: Are we Moving Forward?	71

Endometriosis-associated pain: mechanism, neuroimmune signature, and translational precision strategies	68
Current Challenges and Future Directions in the Assessment of Glucocorticoid Status	67
Biological and Therapeutic Implications of the Tumor Microenvironment in Pituitary Adenomas	66
Contemporary Biological Insights and Clinical Management of Craniopharyngioma	66
Correction to: “Imaging of Pheochromocytomas and Paragangliomas”	65
Insulin Resistance in Type 1 Diabetes: Pathophysiological, Clinical, and Therapeutic Relevance	64
Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction	64
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia	62
Steroid receptor coactivators: from basic research to translational opportunities	61
Endotrophin, a Key Marker and Driver for Fibroinflammatory Disease	59
Glycated CD59: a novel biomarker for gestational diabetes	59
Imaging of Pheochromocytomas and Paragangliomas	58
Adiponectin and Adiponectin Receptors in Atherosclerosis	58
Subtyping of Primary Aldosteronism by Adrenal Venous Sampling	57
Glycerol and Glycerol-3-Phosphate: Multifaceted Metabolites in Metabolism, Cancer, and Other Diseases	55
International Consensus Guideline on Small for Gestational Age: Etiology and Management From Infancy to Early Adulthood	55
The Cortisol Awakening Response: Regulation and Functional Significance	54
Epigenetics and disease progression in neuroendocrine neoplasms	53
Stem Cells of the Hypothalamic-Pituitary-Adrenal Axis	52
Molecular and Clinical Spectrum of Primary Hyperparathyroidism	51
G Protein-coupled and Membrane Tyrosine Kinase Receptor Relationships Yield Therapeutic Opportunities	47
Molecular Developments in Parasellar Tumors and Potential Therapeutic Implications	47
Endocrine Controls of Skin Aging	46
Medullary Thyroid Cancer: Updates and Challenges	46
The Impact of Estrogen Deficiency on Liver Metabolism: Implications for Hormone Replacement Therapy	46
Protective Factors and the Pathogenesis of Complications in Diabetes	44
Retraction and Replacement of: “Effects of Maternal Vitamin D Supplementation on Childhood Health”	43
Epidemiology, Genetic Etiology, and Intervention of Premature Ovarian Insufficiency	42
Syndrome of Inappropriate Antidiuresis: From Pathophysiology to Management	42
Treating the Side Effects of Exogenous Glucocorticoids; Can We Separate the Good From the Bad?	39
Epigenetics and childhood obesity: DNA methylation coordinates environment and gene regulation	38
Teprotumumab for the Treatment of Thyroid Eye Disease	33
Regulators of appetite in mammals—old and new players	32
Molecular Landscape and Therapeutic Strategies in Pediatric Differentiated Thyroid Carcinoma	32
Carbohydrate Ingestion on Exercise Metabolism and Physical Performance	31
Clinical, Pathophysiologic, Genetic, and Therapeutic Progress in Primary Bilateral Macronodular Adrenal Hyperplasia	31
Acromegaly and cardiovascular disease: mechanisms, clinical impact, and evolving management	31
Update on Adipose Tissue and Cancer	30
Molecular Mechanisms of PTH/PTHrP Class B GPCR Signaling and Pharmacological Implications	29
The Hypothalamus-pituitary-adrenocortical Response to Critical Illness: A Concept in Need of Revision	29
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement	29
Crosstalk Between the Neuroendocrine System and Bone Homeostasis	28
Innovative Molecules and Delivery Technologies Enabling the Future of GLP-1-based Therapies	28
Insulin/IGF Axis and the Receptor for Advanced Glycation End Products: Role in Meta-inflammation and Potential in Cancer Therapy	27
The Roles of Natural Killer Cells in Breast Cancer Pathobiology and Their Regulation by Estrogens	26
Placental Steroid Hormones in Preeclampsia: Multilayered Regulation of Endocrine Pathogenesis	26
Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice	25
Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome	24
Endocrine Dysfunction in Primary Mitochondrial Diseases	24
Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease	23

Newer and novel antidiabetic drug classes across the cardiovascular–kidney–metabolic continuum	22
Opposing Metabolic Effects of Growth Hormone and IGF-I: Review and Clinical Implications	21
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease	21
Nuclear receptors shape sepsis pathophysiology	21
Correction to: “Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease”	20
Neurodevelopmental Programming of Adiposity: Contributions to Obesity Risk	20